Advanced search
Publication Cover
Drug Delivery Volume 28, 2021 - Issue 1
Submit an article Journal homepage
2,698
Views
25
CrossRef citations to date
0
Altmetric
Research Article

Combined delivery of salinomycin and docetaxel by dual-targeting gelatinase nanoparticles effectively inhibits cervical cancer cells and cancer stem cells

Qin Wanga The Comprehensive Cancer Center of Drum Tower Hospital, Medical School of Nanjing University & Clinical Cancer Institute of Nanjing University, Nanjing, ChinaORCID Iconhttps://orcid.org/0000-0002-6541-0487View further author information
ORCID Icon,
Ying-Tzu Yena The Comprehensive Cancer Center of Drum Tower Hospital, Medical School of Nanjing University & Clinical Cancer Institute of Nanjing University, Nanjing, ChinaORCID Iconhttps://orcid.org/0000-0002-5601-1134View further author information
ORCID Icon,
Chen Xieb Key Laboratory for Organic Electronics and Information Displays, Institute of Advanced Materials (IAM), Jiangsu National Synergetic Innovation Center for Advanced Materials (SICAM), Nanjing University of Posts & Telecommunications, Nanjing, ChinaORCID Iconhttps://orcid.org/0000-0002-1068-4691View further author information
ORCID Icon,
Fangcen Liuc Department of pathology, Drum Tower Hospital, Medical School of Nanjing University, Nanjing, ChinaORCID Iconhttps://orcid.org/0000-0002-1845-9907View further author information
ORCID Icon,
Qin Liua The Comprehensive Cancer Center of Drum Tower Hospital, Medical School of Nanjing University & Clinical Cancer Institute of Nanjing University, Nanjing, ChinaORCID Iconhttps://orcid.org/0000-0001-9839-8480View further author information
ORCID Icon,
Jia Weia The Comprehensive Cancer Center of Drum Tower Hospital, Medical School of Nanjing University & Clinical Cancer Institute of Nanjing University, Nanjing, ChinaORCID Iconhttps://orcid.org/0000-0003-3024-8878View further author information
ORCID Icon,
Lixia Yua The Comprehensive Cancer Center of Drum Tower Hospital, Medical School of Nanjing University & Clinical Cancer Institute of Nanjing University, Nanjing, ChinaORCID Iconhttps://orcid.org/0000-0002-2595-2169View further author information
ORCID Icon,
Lifeng Wanga The Comprehensive Cancer Center of Drum Tower Hospital, Medical School of Nanjing University & Clinical Cancer Institute of Nanjing University, Nanjing, ChinaORCID Iconhttps://orcid.org/0000-0002-9209-1004View further author information
ORCID Icon,
Fanyan Menga The Comprehensive Cancer Center of Drum Tower Hospital, Medical School of Nanjing University & Clinical Cancer Institute of Nanjing University, Nanjing, ChinaView further author information
,
Rutian Lia The Comprehensive Cancer Center of Drum Tower Hospital, Medical School of Nanjing University & Clinical Cancer Institute of Nanjing University, Nanjing, ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-4800-6156View further author information
ORCID Icon &
Baorui Liua The Comprehensive Cancer Center of Drum Tower Hospital, Medical School of Nanjing University & Clinical Cancer Institute of Nanjing University, Nanjing, ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-2539-7732View further author information
ORCID Icon show all
Pages 510-519 | Received 18 Dec 2020, Accepted 02 Feb 2021, Published online: 04 Mar 2021

Citations (25)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Huaiyu Duan, Li Li & Shiming He. (2023) Advances and Prospects in the Treatment of Pancreatic Cancer. International Journal of Nanomedicine 18, pages 3973-3988.
Read now
Xirui Yin, Yuhui Lu, Miao Zou, Liuli Wang, Xuan Zhou, Yingyu Zhang & Manman Su. (2021) Synthesis and Characterization of Salinomycin-Loaded High-Density Lipoprotein and Its Effects on Cervical Cancer Cells and Cervical Cancer Stem Cells. International Journal of Nanomedicine 16, pages 6367-6382.
Read now

Articles from other publishers (23)

Xianjing Chu, Wentao Tian, Jiaoyang Ning, Gang Xiao, Yunqi Zhou, Ziqi Wang, Zhuofan Zhai, Guilong Tanzhu, Jie Yang & Rongrong Zhou. (2024) Cancer stem cells: advances in knowledge and implications for cancer therapy. Signal Transduction and Targeted Therapy 9:1.
Crossref
Qin Wang, Rui Peng, Haoyue Qi, Ruihan Xu, Wanmin Liu, Fanyan Meng, Shiyao Du, Lixia Yu, Jia Wei, Fangcen Liu & Rutian Li. (2024) Liposome‐based in situ antigen‐modification strategy for “universal” T‐cell‐receptor engineered T cell in cancer immunotherapy. MedComm 5:7.
Crossref
Arunachalam Chinnathambi, Sulaiman Ali Alharbi, Mohankumar Ramar, Palanisamy Arulselvan & Sridhar Muthusami. (2024) Fabrication of folic acid-embedded aminated drug encapsulated zeolitic imidazolate framework as promising drug delivery system for lung cancer. Journal of Materials Research 39:10, pages 1537-1547.
Crossref
Oluwaseun Adebayo Bamodu, Chen-Chih Chung, Thomas R. PisanicIIII & Alexander T. H. Wu. (2024) The intricate interplay between cancer stem cells and cell-of-origin of cancer: implications for therapeutic strategies. Frontiers in Oncology 14.
Crossref
Weili HanZhenglin Shen, Jie Zou, Qiufang Ye, Cheng Ge, Yuqin Zhao, Ting Wang & Yafang Chen. (2024) Therapeutic Approaches of Dual-targeted Nanomedicines for Tumor Multidrug Resistance. Current Drug Delivery 21:2, pages 155-167.
Crossref
Ameneh Jafari, Masoumeh Farahani, Meghdad Abdollahpour-Alitappeh, Asma Manzari-Tavakoli, Mohsen Yazdani & Mostafa Rezaei-Tavirani. (2024) Unveiling diagnostic and therapeutic strategies for cervical cancer: biomarker discovery through proteomics approaches and exploring the role of cervical cancer stem cells. Frontiers in Oncology 13.
Crossref
Yizuo Song, Hejing Liu, Shuya Pan, Xinli Xiang, Miaomiao Ye & Xueqiong Zhu. (2023) Emerging role of mesenchymal stromal cells in gynecologic cancer therapy. Stem Cell Research & Therapy 14:1.
Crossref
Zhengyan Cheng, Hongbo Wang, Zewei Yang, Jiaxu Li & Xing Chen. (2023) LMP2 and TAP2 impair tumor growth and metastasis by inhibiting Wnt/β-catenin signaling pathway and EMT in cervical cancer. BMC Cancer 23:1.
Crossref
Atefeh Safarpour, Marzieh Ebrahimi, Seyed Abolhassan Shahzadeh Fazeli & Mohammad Ali Amoozegar. (2023) A phenol amine molecule from Salinivenus iranica acts as the inhibitor of cancer stem cells in breast cancer cell lines. Scientific Reports 13:1.
Crossref
Qingge Jia, Hongjie Wang, Xin Xiao, Yameng Sun, Xiao Tan, Jia Chai, Yanru Yang, Zhiyong Yin, Mingyang Li, Ke Wang & Jin Liu. (2023) UCHL1 acts as a prognostic factor and promotes cancer stemness in cervical squamous cell carcinoma. Pathology - Research and Practice 247, pages 154574.
Crossref
Chensong Zhang, Jiachi Ma, Qingkang Wang, Yuanpeng Wang, Zhuangzhuang Kang, Yimin Chen, Zhenzhen Hui & Xin Wang. (2023) pH/Thermal Dual-Sensitive Nanoparticle-Hydrogel Composite Based on Pluronic and Carboxymethyl Chitosan for In Situ Injection and Enhanced Chemo-Photothermal Antitumor Effect. ACS Applied Nano Materials.
Crossref
Gang Xu, Kun Tang, Ying Hao, Xiaolei Wang & Lulu Sui. (2022) Polymeric Nanocarriers Loaded with a Combination of Gemcitabine and Salinomycin: Potential Therapeutics for Liver Cancer Treatment. Journal of Cluster Science 34:2, pages 841-852.
Crossref
Yashoda Mariappa Hegde, Panneerselvam Theivendren, Geetha Srinivas, Monashilpa Palanivel, Nivetha Shanmugam, Selvaraj Kunjiappan, Sivakumar Vellaichamy, Murugananthan Gopal & Senthil Rajan Dharmalingam. (2023) A Recent Advancement in Nanotechnology Approaches for the Treatment of Cervical Cancer. Anti-Cancer Agents in Medicinal Chemistry 23:1, pages 37-59.
Crossref
K. Laxmi Swetha, Kavya Sree Maravajjala, Shyh-Dar Li, Manu Smriti Singh & Aniruddha Roy. (2022) Breaking the niche: multidimensional nanotherapeutics for tumor microenvironment modulation. Drug Delivery and Translational Research 13:1, pages 105-134.
Crossref
Xu Guo, Sui Chen, Sihan Wang, Hao Zhang, Fanxing Yin, Panpan Guo, Xiaoxu Zhang, Xuesong Liu & Yanshuo Han. (2022) CircRNA-Based Cervical Cancer Prognosis Model, Immunological Validation and Drug Prediction. Current Oncology 29:11, pages 7994-8018.
Crossref
Yujing Shi, Qing Gao, Zeyuan Liu, Gefenqiang Shen, Xinchen Sun & Xiaoke Di. (2022) Identification of Immune and Hypoxia Risk Classifier to Estimate Immune Microenvironment and Prognosis in Cervical Cancer. Journal of Oncology 2022, pages 1-20.
Crossref
Wenhao Liao, Yuchen Li, Jing Wang, Maoyuan Zhao, Nianzhi Chen, Qiao Zheng, Lina Wan, Yu Mou, Jianyuan Tang & Zhilei Wang. (2022) Natural Products-Based Nanoformulations: A New Approach Targeting CSCs to Cancer Therapy. International Journal of Nanomedicine Volume 17, pages 4163-4193.
Crossref
Dongyao Wang, Yuxiao Tang, Fei Feng, Minyu Qi, Jiahao Fang, Ying Zhang, Yifeng Chai, Yan Cao & Diya Lv. (2022) Investigation of the apoptosis‐inducing effect of docetaxel by comprehensive LC–MS–based metabolomics and network pharmacology approaches. Biomedical Chromatography 36:9.
Crossref
Xinyue Wang, Jiahui Gao, Chunhua Li, Chen Xu, Xiang Li, Fanyan Meng, Qin Liu, Qin Wang, Lixia Yu, Baorui Liu & Rutian Li. (2022) In situ gelatinase-responsive and thermosensitive nanocomplex for local therapy of gastric cancer with peritoneal metastasis. Materials Today Bio 15, pages 100305.
Crossref
Suat Erdogan, Riza Serttas, Kader Turkekul & Ilker Dibirdik. (2022) The synergistic anticancer effect of salinomycin combined with cabazitaxel in CD44+ prostate cancer cells by downregulating wnt, NF-κB and AKT signaling. Molecular Biology Reports 49:6, pages 4873-4884.
Crossref
Riccardo Di Fiore, Sherif Suleiman, Rosa Drago-Ferrante, Yashwanth Subbannayya, Francesca Pentimalli, Antonio Giordano & Jean Calleja-Agius. (2022) Cancer Stem Cells and Their Possible Implications in Cervical Cancer: A Short Review. International Journal of Molecular Sciences 23:9, pages 5167.
Crossref
Somayyeh Mirzaeinia, Sedighe Zeinali, Nediljko Budisa & Hamid Reza Karbalaei-Heidari. (2022) Targeted Codelivery of Prodigiosin and Simvastatin Using Smart BioMOF: Functionalization by Recombinant Anti-VEGFR1 scFv. Frontiers in Bioengineering and Biotechnology 10.
Crossref
Shangui Liu, Abdur Rauf Khan, Xiaoye Yang, Bo Dong, Jianbo Ji & Guangxi Zhai. (2021) The reversal of chemotherapy-induced multidrug resistance by nanomedicine for cancer therapy. Journal of Controlled Release 335, pages 1-20.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.